The Biosensor for COVID-19 Market is expected to register a CAGR of 10.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented By Product Type (Wearable Biosensors, Biosensor Detection, Others. On the basis of treatment, the market is categorized as Hospital, Clinic, Other). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Biosensor for COVID-19 Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Biosensor for COVID-19 Market Segmentation
Product Type- Wearable Biosensors
- Biosensor Detection
- Others
- Hospital
- Clinic
- Other
Strategic Insights
Biosensor for COVID-19 Market Growth Drivers- Increased Demand for Rapid Diagnostics: The biosensor market has been greatly impacted due to the increased demand for rapid and reliable COVID-19 diagnostic tests. I comes without doubt that the point of care testing has increased as the healthcare systems attempt to control the pandemic. Biosensors give results within a short period; thus, they help in making treatment and containment decisions which aids in any war against a virus.
- Advancements in Biosensor Technology: The technology of biosensors has undergone some recent improvements that are driving the growth of the market due to increased the sensitivity and specificity of the biosensors and their ease of application. Developments of this kinds include hand -held devices and lab-on-chip systems which are revolutionizing diagnosis and treatment of COVID-19. Such developments are taken into consideration due to the demand for the testing solutions in the development centers, hospitals, and home leading to growth in the market opportunity.
- Growing Focus on Public Health Surveillance: With the need to understand the disease spread and control COVID-19, there has been an upsurge in the demand for biosensors for monitoring purposes. As a viable solution, these governments and health organizations are focusing on the implementation of sophisticated diagnostic devices for infections monitoring and controlling purposes. An already existing need for primary intervention allows biosensors to be easily integrated in disease control management program.
- Shift Toward Home Testing Solutions: Another important development in the biosensor segment for COVID-19 is the move to activities aimed at home testing solutions. Given the fact that the consumers are looking for better and faster ways to take care of their health, a number of companies are bringing biosensors to the consumer market so that they can test for COVID-19 at home. This trend not only makes health care more accessible but also promotes better health practices as people tend to monitor their health more regularly.
- Integration of Digital Health Technologies: It is interesting to observe that the convergence of biosensor functions with those of digital health technologies is taking center stage. A lot of biosensor developers are now adding mobile apps and cloud services for instant results and health monitoring services for users. In this way, it improves the management of information and enables the attraction of clients by facilitating health service delivery even when distance is an issue.
- Focus on Multi-Pathogen Detection: However, there is already evident technology advancement focusing on developing multisensor biosensors for numerous pathogens including those which causes different variants of COVID-19 and other influenza strains. This multiple capabilities is decent for all-round public health interventions. Other than that, these high performance biosensing systems can be utilized for diagnosis of multiple diseases enabling patients to be managed more effectively and epidemics handled better.
- Expansion into Global Markets: The age of COVID-19 presents the most attractive potential for the expansion of the biosensor market especially to the underdeveloped nations. As countries develop their healthcare systems and the need for quick test grows, manufacturers are able to design their products accordingly. In this regard, collaboration with local governments and healthcare institutions will be beneficial in its market growth and support health policy in this region.
- Development of Next-Generation Biosensors: Next-generation biosensors are at the heart of the technological disruption with dramatically advanced measurements and varied levels of miniaturization. Use of composite materials like nanostructures and biosensors research may help create solutions which are better than what is on the mmarket today. Funds directed to R&D in these innovations can help companies attain the top rank in the biosensor industry and satisfy changing needs in medicine.
- Integration with Telehealth Services: The combination of biosensors and telehealth services can also be regarded as a great opportunity in the market for COVID 19. In light of the increasing appeal of remote healthcare, there is a growing trend of integrating biosensor technology into telemedicine platforms for effective patient monitoring and data exchange. This combination is beneficial in that it improves the quality of care, leads to better health results, and encourages the use of biosensors for everyday health management of an expanding audience.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Biosensor for COVID-19 Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Biosensor for COVID-19 Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Abbott ,Siemens ,Medtronic ,F. Hoffman-La Roche ,Acon Laboratories ,Universal Biosensors ,LifeScan ,LifeSensors ,Nova Biomedical ,Pharmaco-Kinesis Corporation are the some of the key market players operating in the biosensor for COVID-19 market
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
The North America region accounts for highest revenue share biosensor for COVID-19 market
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
increased demand for rapid diagnostics and advancements in biosensor technology is the major factors boosting the biosensor for COVID-19 market growth
The market is expected to grow at a CAGR of 10.5%
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Biosensor For COVID19 Market - By Type
1.3.2 Biosensor For COVID19 Market - By End Use
1.3.3 Biosensor For COVID19 Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. BIOSENSOR FOR COVID19 MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOSENSOR FOR COVID19 MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. BIOSENSOR FOR COVID19 MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOSENSOR FOR COVID19 - GLOBAL MARKET OVERVIEW
6.2. BIOSENSOR FOR COVID19 - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOSENSOR FOR COVID19 MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. WEARABLE BIOSENSORS
7.3.1. Overview
7.3.2. Wearable Biosensors Market Forecast and Analysis
7.4. BIOSENSOR DETECTION
7.4.1. Overview
7.4.2. Biosensor Detection Market Forecast and Analysis
7.5. OTHER
7.5.1. Overview
7.5.2. Other Market Forecast and Analysis
8. BIOSENSOR FOR COVID19 MARKET - REVENUE AND FORECASTS TO 2028 - END USE
8.1. OVERVIEW
8.2. END USE MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. BIOSENSOR FOR COVID19 MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Biosensor For COVID19 Market Overview
9.1.2 North America Biosensor For COVID19 Market Forecasts and Analysis
9.1.3 North America Biosensor For COVID19 Market Forecasts and Analysis - By Type
9.1.4 North America Biosensor For COVID19 Market Forecasts and Analysis - By End Use
9.1.5 North America Biosensor For COVID19 Market Forecasts and Analysis - By Countries
9.1.5.1 United States Biosensor For COVID19 Market
9.1.5.1.1 United States Biosensor For COVID19 Market by Type
9.1.5.1.2 United States Biosensor For COVID19 Market by End Use
9.1.5.2 Canada Biosensor For COVID19 Market
9.1.5.2.1 Canada Biosensor For COVID19 Market by Type
9.1.5.2.2 Canada Biosensor For COVID19 Market by End Use
9.1.5.3 Mexico Biosensor For COVID19 Market
9.1.5.3.1 Mexico Biosensor For COVID19 Market by Type
9.1.5.3.2 Mexico Biosensor For COVID19 Market by End Use
9.2. EUROPE
9.2.1 Europe Biosensor For COVID19 Market Overview
9.2.2 Europe Biosensor For COVID19 Market Forecasts and Analysis
9.2.3 Europe Biosensor For COVID19 Market Forecasts and Analysis - By Type
9.2.4 Europe Biosensor For COVID19 Market Forecasts and Analysis - By End Use
9.2.5 Europe Biosensor For COVID19 Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Biosensor For COVID19 Market
9.2.5.1.1 Germany Biosensor For COVID19 Market by Type
9.2.5.1.2 Germany Biosensor For COVID19 Market by End Use
9.2.5.2 France Biosensor For COVID19 Market
9.2.5.2.1 France Biosensor For COVID19 Market by Type
9.2.5.2.2 France Biosensor For COVID19 Market by End Use
9.2.5.3 Italy Biosensor For COVID19 Market
9.2.5.3.1 Italy Biosensor For COVID19 Market by Type
9.2.5.3.2 Italy Biosensor For COVID19 Market by End Use
9.2.5.4 Spain Biosensor For COVID19 Market
9.2.5.4.1 Spain Biosensor For COVID19 Market by Type
9.2.5.4.2 Spain Biosensor For COVID19 Market by End Use
9.2.5.5 United Kingdom Biosensor For COVID19 Market
9.2.5.5.1 United Kingdom Biosensor For COVID19 Market by Type
9.2.5.5.2 United Kingdom Biosensor For COVID19 Market by End Use
9.2.5.6 Russia Biosensor For COVID19 Market
9.2.5.6.1 Russia Biosensor For COVID19 Market by Type
9.2.5.6.2 Russia Biosensor For COVID19 Market by End Use
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Biosensor For COVID19 Market Overview
9.3.2 Asia-Pacific Biosensor For COVID19 Market Forecasts and Analysis
9.3.3 Asia-Pacific Biosensor For COVID19 Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Biosensor For COVID19 Market Forecasts and Analysis - By End Use
9.3.5 Asia-Pacific Biosensor For COVID19 Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Biosensor For COVID19 Market
9.3.5.1.1 Australia Biosensor For COVID19 Market by Type
9.3.5.1.2 Australia Biosensor For COVID19 Market by End Use
9.3.5.2 China Biosensor For COVID19 Market
9.3.5.2.1 China Biosensor For COVID19 Market by Type
9.3.5.2.2 China Biosensor For COVID19 Market by End Use
9.3.5.3 India Biosensor For COVID19 Market
9.3.5.3.1 India Biosensor For COVID19 Market by Type
9.3.5.3.2 India Biosensor For COVID19 Market by End Use
9.3.5.4 Japan Biosensor For COVID19 Market
9.3.5.4.1 Japan Biosensor For COVID19 Market by Type
9.3.5.4.2 Japan Biosensor For COVID19 Market by End Use
9.3.5.5 South Korea Biosensor For COVID19 Market
9.3.5.5.1 South Korea Biosensor For COVID19 Market by Type
9.3.5.5.2 South Korea Biosensor For COVID19 Market by End Use
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Biosensor For COVID19 Market Overview
9.4.2 Middle East and Africa Biosensor For COVID19 Market Forecasts and Analysis
9.4.3 Middle East and Africa Biosensor For COVID19 Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Biosensor For COVID19 Market Forecasts and Analysis - By End Use
9.4.5 Middle East and Africa Biosensor For COVID19 Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Biosensor For COVID19 Market
9.4.5.1.1 South Africa Biosensor For COVID19 Market by Type
9.4.5.1.2 South Africa Biosensor For COVID19 Market by End Use
9.4.5.2 Saudi Arabia Biosensor For COVID19 Market
9.4.5.2.1 Saudi Arabia Biosensor For COVID19 Market by Type
9.4.5.2.2 Saudi Arabia Biosensor For COVID19 Market by End Use
9.4.5.3 U.A.E Biosensor For COVID19 Market
9.4.5.3.1 U.A.E Biosensor For COVID19 Market by Type
9.4.5.3.2 U.A.E Biosensor For COVID19 Market by End Use
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Biosensor For COVID19 Market Overview
9.5.2 South and Central America Biosensor For COVID19 Market Forecasts and Analysis
9.5.3 South and Central America Biosensor For COVID19 Market Forecasts and Analysis - By Type
9.5.4 South and Central America Biosensor For COVID19 Market Forecasts and Analysis - By End Use
9.5.5 South and Central America Biosensor For COVID19 Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Biosensor For COVID19 Market
9.5.5.1.1 Brazil Biosensor For COVID19 Market by Type
9.5.5.1.2 Brazil Biosensor For COVID19 Market by End Use
9.5.5.2 Argentina Biosensor For COVID19 Market
9.5.5.2.1 Argentina Biosensor For COVID19 Market by Type
9.5.5.2.2 Argentina Biosensor For COVID19 Market by End Use
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL BIOSENSOR FOR COVID19 MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. BIOSENSOR FOR COVID19 MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SIEMENS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MEDTRONIC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMAN-LA ROCHE
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ACON LABORATORIES
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. UNIVERSAL BIOSENSORS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LIFESCAN
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. LIFESENSORS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVA BIOMEDICAL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PHARMACO-KINESIS CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Abbott
2. Siemens
3. Medtronic
4. F. Hoffman-La Roche
5. Acon Laboratories
6. Universal Biosensors
7. LifeScan
8. LifeSensors
9. Nova Biomedical
10. Pharmaco-Kinesis Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For